Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPA
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,443
Award facts
- Contract value 100% obligated
- $30,442.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $30,442.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. This firm fixed-price delivery order, awarded on December 9, 2025, with an ultimate completion date of December 10, 2025, represents one of multiple orders issued to the vendor for pharmaceutical products and medical consumables supporting Department of Defense healthcare operations. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
DMS Pharmaceutical Group operates under a single-award indefinite delivery contract (SPE2DR) established under the broader $30.3 billion PPV-G GEN V acquisition strategy, which became effective November 13, 2025, with a ceiling value of $499.999 billion and completion date of December 31, 2036. The parent contract authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support military healthcare facilities worldwide. The vendor's extensive pharmaceutical portfolio includes oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals, positioning it as a critical supplier within the federal pharmaceutical supply chain for Department of Defense operations globally.
Quick answers
Who was awarded contract SPE2DU26FEMPA?
SPE2DU26FEMPA was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DU26FEMPA worth?
The government has obligated $30,443 on SPE2DU26FEMPA.
Is contract SPE2DU26FEMPA an order under another contract?
Yes. SPE2DU26FEMPA is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPA competed?
The extent of competition for SPE2DU26FEMPA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award